$SVRA
Savara Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Austin, TX
SVRA chart
What traders are saying about $SVRA
Latest postsSavara Inc news
- Nameless, Wahu, Savara and Other Stars Celebrate Bien’s Upcoming Album Alusa Continua
Ghafla! ·
- Savara Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- SVRA SWOT Analysis: Financial Challenges and Regulatory Milestones Revealed in 10-Q Filing
GuruFocus ·
- Savara 3Q 2026: EPS ($0.17) — 10-Q Summary
TradingView ·
- Charisma, Nameless, Wahu, Bensoul, Savara Share Their Verdict on Bien’s Alusa Continua Album
Mpasho ·
- Savara (SVRA) Jumps 10% But Does Its 8.5x P B Still Look Pricey?
Simply Wall St ·
- HOT Like You: Infinix and Savara launch HOT 70 Series to celebrate Kenya’s Slash Youth Generation
Daily Nation ·
- Savara earnings loom as FDA decision on rare lung drug nears
Investing.com Canada ·
- Why Did Insmed Stock Jump?
trefis.com ·
- Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment
Yahoo Finance ·
- Will Long‑Term Molgramostim Data at CHEST 2026 Change Savara's (SVRA) Autoimmune PAP Narrative?
Yahoo Finance ·
- Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026
Yahoo Finance ·
Savara Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$118.8M | -$95.9M | -$54.7M | -$38.1M |
| Diluted EPS | $-0.53 | $-0.48 | $-0.33 | $-0.25 |
| Total assets (year end) | $253.4M | $212.9M | $177.6M | $139.8M |
| Cash and equivalents (year end) | $33.2M | $15.1M | $26.6M | $52.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Savara Inc
- Ticker
- SVRA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Austin, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1160308
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Savara Inc listed on?
Savara Inc trades on the Nasdaq under the ticker symbol SVRA.
What industry is Savara Inc in?
Savara Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Savara Inc headquartered?
Savara Inc's business address on file with the SEC is in Austin, TX.
When does Savara Inc's fiscal year end?
Savara Inc's fiscal year ends on December 31.
How much revenue did Savara Inc report?
Savara Inc reported $257,000 in revenue for calendar year 2020, according to its SEC filings.